Actualización en el uso del PET/CT en sarcoma de Ewing, a propósito de un caso
Date
2020
Type:
Article
item.page.extent
4 p.
item.page.accessRights
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.other
item.page.references
Abstract
The use of positron emission tomography with computed tomography (PET/CT) for adult cancer patients is widespread, however, its use in pediatric patients is limited by fear of radiation, monetary cost and lack of awareness of its greater sensitivity in the evaluation of some types of tumors. Ewing's sarcoma is one of the primary pediatric malignancies in which PET/CT with 18F-labeled fluorodeoxyglucose (18F-FDG) has demonstrated greater sensitivity in the evaluation of bone metastases compared to scintigraphy, as well as in the evaluation of treatment response. We report a 13 years old female consulting for retrosternal pain. A chest CT scan showed an infiltrating mass originating in the sternum. A biopsy confirmed the presence of an Ewing sarcoma. The tumor was staged with PET/CT which showed multiple bone lesions not visible in previous studies.
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Revista Médica de Chile 2020; 148: 1504-1507
Keywords
Bone marrow, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Radionuclide Imaging, Sarcoma, Ewing